España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Arcus Biosciences
RCUS
NYSE
Watchlist
Get Report
Perks
Buy
Compare Brokers
$13.73
-0.63
-4.39%
After Hours: 9:28 AM EDT
15 minutes delayed
Get Report
Watch
Arcus Biosciences (RCUS) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Arcus Biosciences (NYSE:RCUS) Stock
Arcus Biosciences Stock (NYSE: RCUS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, July 05, 2024
Cantor Fitzgerald Reiterates Overweight on Ar...
Benzinga Newsdesk
Monday, June 24, 2024
Truist Securities Maintains Buy on Arcus Bios...
Benzinga Newsdesk
Monday, June 10, 2024
Arcus Biosciences In Collaboration With Gilea...
Benzinga Newsdesk
Monday, June 03, 2024
After Disappointing Bladder Cancer Data, Gilead Announces Encouraging Data From Gastric, Colorectal Cancer Studies
Vandana Singh
Citigroup Maintains Buy on Arcus Biosciences,...
Benzinga Newsdesk
Sunday, June 02, 2024
Gilead And Arcus Announced Etrumadenant Plus Zimberelimab, FOLFOX, And Bevacizumab Reduce Death Risk By 63% And Disease Progression by 73% vs Regorafenib In Phase 1b/2 Trial For Third-Line Metastatic Colorectal Cancer
Charles Gross
Friday, May 24, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, May 09, 2024
Wedbush Reiterates Outperform on Arcus Biosci...
Benzinga Newsdesk
Wednesday, May 08, 2024
Arcus Biosciences Q1 2024 GAAP EPS $(0.05) Be...
Benzinga Newsdesk
Wednesday, April 24, 2024
Arcus Biosciences To Present New Data From Ph...
Benzinga Newsdesk
Monday, March 25, 2024
Navigating 5 Analyst Ratings For Arcus Biosciences
Benzinga Insights
Truist Securities Reiterates Buy on Arcus Bio...
Benzinga Newsdesk
Thursday, February 22, 2024
Arcus Biosciences shares are trading higher a...
Benzinga Newsdesk
Critical Insights From Arcus Biosciences Analyst Ratings: What You Need To Know
Benzinga Insights
Wedbush Reiterates Outperform on Arcus Biosci...
Benzinga Newsdesk
Wednesday, February 21, 2024
Recap: Arcus Biosciences Q4 Earnings
Benzinga Insights
Arcus Biosciences Q4 2023 GAAP EPS $(1.08) Mi...
Benzinga Newsdesk
Earnings Scheduled For February 21, 2024
Benzinga Insights
Tuesday, February 20, 2024
Preview: Arcus Biosciences's Earnings
Benzinga Insights
Thursday, February 01, 2024
$320M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
Avi Kapoor
Tuesday, January 30, 2024
Key Takeaways From Arcus Biosciences Analyst Ratings
Benzinga Insights
Wedbush Maintains Outperform on Arcus Bioscie...
Benzinga Newsdesk
Mizuho Maintains Buy on Arcus Biosciences, Lo...
Benzinga Newsdesk
Pharma Giant Gilead Raises Stake In Cancer-Focused Arcus Biosciences, Stock Soars
Vandana Singh
Monday, January 29, 2024
Gilead and Arcus Announce Amended Collaborati...
Benzinga Newsdesk
Wednesday, January 17, 2024
Wedbush Reiterates Outperform on Arcus Biosci...
Benzinga Newsdesk
Tuesday, January 16, 2024
Arcus Biosciences Data From Phase 1b Study Of...
Benzinga Newsdesk
Monday, December 04, 2023
Exelixis And Arcus Biosciences Announce Clini...
Benzinga Newsdesk
Monday, November 13, 2023
Morgan Stanley Maintains Overweight on Arcus ...
Benzinga Newsdesk
Wednesday, November 08, 2023
What 9 Analyst Ratings Have To Say About Arcus Biosciences
Benzinga Insights
Cantor Fitzgerald Maintains Overweight on Arc...
Benzinga Newsdesk
Tuesday, November 07, 2023
Arcus Biosciences: Q3 Earnings Insights
Benzinga Insights
Arcus Biosciences Q3 2023 Gaap EPS $(0.94) Be...
Benzinga Newsdesk
Positive News For Gastric Cancers - Gilead/Arcus Biosciences' Combination Cancer Therapy Shows Encouraging Clinical Activity
Vandana Singh
Earnings Scheduled For November 7, 2023
Benzinga Insights
Monday, November 06, 2023
Gilead And Arcus Report New Data Showing Enco...
Benzinga Newsdesk
Tuesday, October 17, 2023
Arcus Biosciences To Present Data From Ongoin...
Benzinga Newsdesk
Thursday, October 05, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Tuesday, October 03, 2023
Expert Ratings for Arcus Biosciences
Benzinga Insights
Mizuho Reiterates Buy on Arcus Biosciences, M...
Benzinga Newsdesk
Tuesday, September 12, 2023
Where Arcus Biosciences Stands With Analysts
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Ar...
Benzinga Newsdesk
Thursday, September 07, 2023
Cantor Fitzgerald Reiterates Overweight on Ar...
Benzinga Newsdesk
Wednesday, September 06, 2023
Truist Securities Reiterates Buy on Arcus Bio...
Benzinga Newsdesk
Tuesday, September 05, 2023
B of A Securities Maintains Neutral on Arcus ...
Benzinga Newsdesk
Thursday, August 24, 2023
5 Analysts Have This to Say About Arcus Biosciences
Benzinga Insights
Citigroup Maintains Buy on Arcus Biosciences,...
Benzinga Newsdesk
Wednesday, August 23, 2023
Who Are Other Players Gaining From Roche's Accidental Lung Cancer Data Update
Vandana Singh
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Why Grab Holdings Are Trading Higher By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
